Ask AI
SOLTI 2104 PremiÈRe
SOLTI-2104-PremiÈRe: Phase II Trial of Elacestrant ± Triptorelin in Premenopausal Women With Estrogen Receptor (ER)–Positive/HER2-Negative Early Breast Cancer

Released: December 19, 2025

Activity

Progress
1
Course Completed
Activity Information

Released: December 19, 2025